- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
ProSense received FDA clearance and approval following a study conducted in Nîmes, France.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ProSense received FDA clearance and approval following a study conducted in Nîmes, France.
Who's involved
What this event is mainly aboutKeep exploring
Part of
A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Also in this story
- A partnership with BARDA has accelerated the development of SCY-247 for the company.
- A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.
- Approval leads to procurement process initiation.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
The entities involved
Coverage
Newest first; wire copies grouped- PR NewswireIceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy Independent study reports pain scores declined from a median of 8 on a scale of 0-10 to a med